2012 thomson reuters australia citation & innovation awards

More documents

Recommendations

Info

INNOVATION AWARDEES Innovation Category: Corporate – Bio/Med (Large) ResMed Ltd 1 Elizabeth Macarthur Drive Bella Vista NSW 2153 ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleepdisordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleepdisordered breathing. When ResMed was formed in 1989, its primary purpose was to commercialise a device for treating obstructive sleep apnea (OSA), a major subset of SDB. Developed in 1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful non-invasive treatment of OSA. Since 1989, ResMed has maintained its focus on SDB, which is gaining greater public and physician awareness. Operations have grown dramatically through the introduction of a number of highly innovative product lines. *Mr Mark Abourizk, Vice President of Intellectual Property & Legal Counsel at ResMed Limited will be accepting the award on behalf of ResMed Limited. Innovation Category: Corporate – Bio/Med (SME) CathRx 5 Parkview Drive Homebush Bay NSW 2127 CathRx is focussed on developing, patenting and producing a full range of high quality Electrophysiology (EP) Catheters, used in the diagnosis and treatment of cardiac arrhythmias. CathRx’s goal is to provide high quality EP Catheters at costs that will make EP procedures far more affordable. CathRx design a full range of EP Catheters, featuring durable materials to ensure high performance during use. CathRx also produce catheters that have a unique, patented design feature: Modular Construction. This enables manufacturing and remanufacturing with selected partners globally to drive huge hospital savings. CathRx is the only Catheter technology company in the world that offers Remanufacturable Catheters. This offers hospitals EP Catheters that have passed the same quality control tests that all new Catheters must pass, but at significantly reduced prices. CathRx has also designed and patented an Advanced AF Ablation program, which uses irrigated, multi-electrode, linear lesion technology. This technology has the potential to help patients worldwide with a safe and effective AF Ablation system. *Mr Roman Greifeneder, Director of Research & Development and Operations at CathRx Ltd will be accepting the award on behalf of CathRx Ltd. 17
INNOVATION AWARDEES Innovation Category: Corporate – Tech (Large) Rio Tinto Ltd Head Office 120 Collins Street Melbourne VIC 3000 Rio Tinto is a leading international mining group, combining Rio Tinto plc, a London listed public company headquartered in the UK, and Rio Tinto Limited, which is listed on the Australian Stock Exchange, with executive offices in Melbourne. The two companies are joined in a dual listed companies (DLC) structure as a single economic entity, called the Rio Tinto Group. To deliver superior returns to shareholders over time, Rio Tinto takes a long term and responsible approach to the Group’s business. This means concentrating on the development of first class orebodies into large, long life and efficient operations, capable of sustaining competitive advantage through business cycles. Rio Tinto is a world leader in finding, mining and processing the Earth’s mineral resources. Our products help fulfil vital consumer needs and improve living standards. Rio Tinto operate, and eventually close, our operations safely, responsibly and sustainably. Rio Tinto’s interests are diverse both in geography and product. Rio Tinto work in some of the world’s most difficult terrains and climates. Most of their assets are in Australia and North America, but they also operate in Europe, South America, Asia and Africa. Their businesses include open pit and underground mines, mills, refineries and smelters as well as a number of research and service facilities. Rio Tinto operates as a global organisation, sharing best practices across the Group. Their values - accountability, respect, teamwork and integrity - are expressed through their business principles, policies and standards. Rio Tinto set these out in our worldwide code of business conduct, the way they work. Their values underpin the way they manage the economic, social and environmental effects of their operations, and how they govern their business. * Mr John McGagh, Head of Innovation at Rio Tinto will be accepting the award on behalf of Rio Tinto. 18
Page 1 and 2: 2012 THOMSON REUTERS AUSTRALIA CITA
Page 3 and 4: WELCOME Welcome to the 2012 Thomson
Page 5 and 6: KEYNOTE SPEAKERS Professor Brian P.
Page 7 and 8: SPEAKERS David A. Pendlebury joined
Page 9 and 10: SPEAKERS Dr Nicola Lake is a Melbou
Page 11 and 12: CITATION & INNOVATION AWARD WINNERS
Page 13 and 14: CITATION AWARDEES Research Field: B
Page 15 and 16: CITATION AWARDEES Research Field: G
Page 17: CITATION AWARDEES Research Field: P
Page 21 and 22: INNOVATION AWARDEES Innovation Cate
Page 23 and 24: ABOUT THOMSON REUTERS Thomson Reute

2012 thomson reuters australia citation & innovation awards

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?